arrow
J

Jean M. Mulcahy Levy

university of colorado school of medicine
H指数:33
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chromosome 6q mediated loss of LATS1 tumour suppression as a targetable mechanism of ultra-high-risk posterior fossa A ependymoma

染色体6q介导的LATS1肿瘤抑制功能丧失作为超高风险后颅窝A型室管膜瘤的可靶向机制

2026-10-130
OAAI
Response to Wyld et al

对Wyld等人研究的回应

2026-10-090
PRE
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology and European Association of Neuro-Oncology consensus review on clinical management and future directions

BRAF突变型胶质瘤在成人和儿童中的研究:神经肿瘤学会和欧洲神经肿瘤学会关于临床管理与未来方向的共识综述

2026-06-080
OAAI
Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality

播散性儿科低级别胶质瘤和脑积水:一项跨国联盟对发病率和死亡率的分析

2025-12-120
PRE
Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma

整合的播散性儿童低级别胶质瘤临床与分子全景

2025-10-210
PRE
Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations

多维度分析儿童低级别胶质瘤和神经节胶质瘤揭示了一种与BRAF突变相关的独特肿瘤微环境

2025-06-300
OAAI
BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma

BRAF/MEK抑制诱导BRAFV600E突变型胶质瘤细胞状态转变,增强免疫检查点敏感性

2025-06-120
OA
Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growth

间质肿瘤细胞中染色质压缩导致的LDOC1丢失是PFA1室管膜瘤生长所必需的。

2025-02-040
PRE
INTEGRATED CLINICAL AND MOLECULAR CHARACTERIZATION OF 200 DISSEMINATED PEDIATRIC LOW-GRADE GLIOMAS
2024-06-180
OAAI